Skip to main navigation Skip to search Skip to main content

The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases

  • Femke M. Feringa
  • , Sascha J. Koppes-den Hertog
  • , Lian Y. Wang
  • , Rico J.E. Derks
  • , Iris Kruijff
  • , Lena Erlebach
  • , Jorin Heijneman
  • , Ricardo Miramontes
  • , Nadine Pömpner
  • , Niek Blomberg
  • , Damien Olivier-Jimenez
  • , Lill Eva Johansen
  • , Alexander J. Cammack
  • , Ashling Giblin
  • , Christina E. Toomey
  • , Indigo V.L. Rose
  • , Hebao Yuan
  • , Michael E. Ward
  • , Adrian M. Isaacs
  • , Martin Kampmann
  • Deborah Kronenberg-Versteeg, Tammaryn Lashley, Leslie M. Thompson, Alessandro Ori, Yassene Mohammed, Martin Giera*, Rik van der Kant*
*Corresponding author for this work

Research output: Contribution to Journal › Article › Academic › peer-review

Abstract

Lipid alterations in the brain have been implicated in many neurodegenerative diseases. To facilitate comparative lipidomic research across brain diseases, we establish a data common named the Neurolipid Atlas that we prepopulated with isogenic induced pluripotent stem cell (iPS cell)-derived lipidomics data for different brain diseases. Additionally, the resource contains lipidomics data of human and mouse brain tissue. Leveraging multiple datasets, we demonstrate that iPS cell-derived neurons, microglia and astrocytes exhibit distinct lipid profiles that recapitulate in vivo lipotypes. Notably, the Alzheimer disease (AD) risk gene ApoE4 drives cholesterol ester (CE) accumulation specifically in human astrocytes and we also observe CE accumulation in whole-brain lipidomics from persons with AD. Multiomics interrogation of iPS cell-derived astrocytes revealed that altered cholesterol metabolism has a major role in astrocyte immune pathways such as the immunoproteasome and major histocompatibility complex class I antigen presentation. Our data commons, available online (https://neurolipidatlas.com/), allows for data deposition by the community and provides a user-friendly tool and knowledge base for a better understanding of lipid dyshomeostasis in neurodegenerative diseases.

Original languageEnglish
Pages (from-to)2142-2164
Number of pages43
JournalNature Metabolism
Volume7
Issue number10
Early online date22 Sept 2025
DOIs
Publication statusPublished - Oct 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025.

Funding

FundersFunder number
Live Like Lou Foundation
Alzheimer’s Research UK
Fritz Lipmann Institute
Medical Research Council
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
UK Dementia Research Institute
National Institute of Neurological Disorders and Stroke
Organization postdoctoral fellowship
Studienstiftung des Deutschen Volkes
European Molecular Biology Laboratory
Leibniz-Gemeinschaft
VU University Medical Center
PhD Scholarship
Alzheimer's AssociationADSF-21-831212-C, 2019-AARG-643165, WE-03-2017-09P, 09150172110086
ZonMw733050515, WE.03-2019-13
International Max Planck Research School for Environmental, Cellular and Molecular MicrobiologyWE.15-2019-16
National Institute on AgingU01 AG072464, R01 AG062359
Chan Zuckerberg Initiative2020-221617, 2022-250474, 2022-250618, 2021-230967
California Institute for Regenerative MedicineT32NS115706, EDUC412812, ADSF-21-816750
Genomics Research and Technology Hub Shared ResourceP30CA62203
National Institutes of HealthR35 NS116872, P01 NS084974-06A1
Gemeinnützige Hertie-StiftungP1230003
ZonMW Enabling Technologies Hotels435005033

    Fingerprint

    Dive into the research topics of 'The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases'. Together they form a unique fingerprint.

    Cite this